Skip to main content
Log in

Generic Medicines

Reducing Cost at the Expense of Quality?

  • Guest Editorial
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Houghton G. Cutting prescribing costs: learning from Birmingham in 1913. BMJ 1989: 299: 1625–8

    Article  PubMed  CAS  Google Scholar 

  2. Macatlhur D. Pharmaceutical distribution in Europe. Changes in the wholesaling and retailing of medicines. London: Financial Times Business Information, 1993

    Google Scholar 

  3. Greenfield PR. Report to the secretary of state for Social services of an informal working group on effective prescribing. London: Department of Health and Social Securily, 1983

    Google Scholar 

  4. Government response to the second report from the health committee session 1993–94. Priority selling in the NHS; the NHS drugs budget. London: Her Majesty’s stationery Office, 1994

  5. Association of the British Pharmaceutical lndustry (ABPI). Annual review 1993–94. London: ABPI, 1994

  6. Government Statistical service. Statistics of prescriptions dispensed in the family health services authorities: England 1983 to 1993. London: Department of Health, 1994

  7. Department of Health and Social Security. Annual report. London: Her Majesty’s Stationery Office, 1973

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Walker, R. Generic Medicines. Pharmacoeconomics 7, 375–377 (1995). https://doi.org/10.2165/00019053-199507050-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199507050-00001

Keywords

Navigation